Bayer | BAYN - Selling And Administration Expenses


Bayer reported EUR4.02B in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Air Liquide EUR 2.57B 1.27B Dec/2024
Akzo Nobel EUR 816M 17M Sep/2026
Alcon AG USD 964M 82M Jun/2026
Amarin USD 18.97M 1.03M Dec/2025
Arkema EUR 219.7M 6.5M Sep/2026
AstraZeneca USD 4.07B 1.73B Sep/2026
BASF EUR 2.16B 123M Sep/2026
Bayer EUR 4.02B 53M Sep/2026
Beiersdorf EUR 282M 11M Jun/2026
Corteva USD 1.16B 287M Jun/2026
Covestro EUR 445M 8M Dec/2025
Essilor EUR 5.75B 139M Jun/2026
Fresenius EUR 823M 63M Sep/2026
Fresenius Medical Care EUR 744M 7.99M Sep/2026
Genmab DKK 205M 39M Jun/2026
Givaudan CHF 561M 25M Dec/2025
GlaxoSmithKline GBP 2.16B 39M Sep/2026
GRIFOLS EUR 326M 37M Sep/2026
Henkel EUR 3.5B 13M Jun/2026
Hikma Pharmaceutical USD 288M 149M Dec/2025
Johnson Matthey GBP 119M 51M Jun/2026
Linde USD 892M 1000K Sep/2026
Merck EUR 1.58B 11M Sep/2026
Novartis USD 3.08B 163M Sep/2026
Nutrien USD 974M 196M Sep/2026
Philips EUR 1.17B 33M Sep/2026
PPG Industries USD 876M 55M Sep/2026
Roche Holding CHF 6.37B 908M Jun/2026
Sanofi EUR 2.31B 325M Sep/2026
SAP EUR 2.7B 24M Sep/2026
Solvay EUR 112M 11M Sep/2026
UCB EUR 1.47B 193M Dec/2025
Vinci EUR 197M 49M Jun/2025